Used in the development and calibration of diagnostic assays for B-cell malignancies. Serves as a critical reference standard in flow cytometry and immunohistochemistry to detect CD19 expression on B cells. Supports research in immunotherapy, particularly in the design and testing of CAR-T cells and bispecific antibodies targeting CD19-positive cancers. Enables consistent evaluation of antibody binding affinity and specificity during therapeutic antibody development.